Four new leads identified for anti-cancer drugs

Lead author Jason Smith undertook a comprehensive study that combined existing knowledge of an enzyme with a specifically tailored computational chemistry approach to identify novel inhibitors. The enzyme (indoleamine 2,3-dioxygenase) has generated excitement amongst researchers over the last decade due to its increasingly recognised role as a drug target, particularly in cancer.

J Smith